Sociedad Americana de Hirudoterapia

Therapeutic Potentials of Medicinal Leech in Chinese Medicine

Review published in American Journal of Chinese Medicine (2024)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewDesarrollo de fármacosEnsayos clínicosFarmacología salivalWu S et al. · American Journal of Chinese Medicine, 2024

Abstract

The use of medicinal leeches in clinical therapy has been employed for a long time, as it was originally recognized for exerting antithrombin effects. These effects were due to the ability of the leech to continuously suck blood while attached to human skin. According to Chinese Pharmacopoei, leeches used in traditional Chinese medicine mainly consist of Whitmania pigra Whitman, Hirudo nipponia Whitman, and Whitmania acranulata, but the latter two species are relatively scarce. The main constituents of leeches are protein and peptide macromolecules. They can be categorized into two categories based on their pharmacological effects. One group consists of active ingredients that directly target the coagulation system, such as hirudin, heparin, and histamine, which are widely known. The other group comprises protease inhibitor components like Decorsin and Hementin. Among these, hirudin secreted by the salivary glands of the leech is the most potent thrombin inhibitor and served as the sole remedy for preventing blood clotting until the discovery of heparin. Additionally, leeches play a significant role in various traditional Chinese medicine formulations. In recent decades, medicinal leeches have been applied in fields including anti-inflammatory treatment, cardiovascular disease management, antitumor treatment, and many other medical conditions. In this review, we present a comprehensive overview of the historical journey and medicinal applications of leeches in various medical conditions, emphasizing their pharmaceutical significance within traditional Chinese medicine. This review offers valuable insights for exploring additional therapeutic opportunities involving the use of leeches in various diseases and elucidating their underlying mechanisms for future research.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAnimalsLeechesMedicine, Chinese TraditionalHumansHirudinsHistamineHeparinAnti-Inflammatory AgentsCardiovascular DiseasesLeechingAntineoplastic AgentsAnticoagulants

Resumen

Comprehensive review of medicinal leech (Whitmania pigra, Hirudo nipponia, Hirudinaria manillensis) applications in traditional Chinese medicine: hirudin, heparin, histamine, Decorsin, Hementin protease inhibitors and their use in anti-inflammatory, cardiovascular, antitumor, and other indications.

Por qué esto importa para la hirudoterapia

This review surveys the historical and current medicinal applications of leeches in traditional Chinese medicine, describing species (Whitmania pigra, Hirudo nipponia, Whitmania acranulata) and key bioactive constituents including hirudin, heparin, histamine, decorsin, and hementin, noting hirudin as the most potent thrombin inhibitor. The review highlights leeches' roles in antithrombotic, anti-inflammatory, cardiovascular, and antitumor applications within traditional formulations. This is directly relevant to ASH's domain, providing a contextual overview of leech-derived therapeutics and their pharmacological significance in traditional Chinese medicine. The publication type is listed as a review; its relevance is primarily contextual.

Citación

Therapeutic Potentials of Medicinal Leech in Chinese Medicine.

Wu S et al. · American Journal of Chinese Medicine, 2024

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.